Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rivaroxaban
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Anticoagulants
- ATC
- B01AF
- Strength
- 15 mg
- Dosage form
- Tablet
- Pack
- 7's
- Registration no.
- 089304
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-11 02:59
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Baroxa (Rivaroxaban) is used for
Rivaroxaban is an anticoagulant, often called a blood thinner, available only on prescription. It works by blocking a substance in the blood (factor Xa) that helps clots to form, so blood flows more easily and dangerous clots are less likely. It comes as tablets, and as granules to make a liquid for children who cannot swallow tablets. How long you take it depends on why it was prescribed.
- Treating blood clots in a leg vein (deep vein thrombosis, DVT) or in the lungs (pulmonary embolism, PE), and helping to stop them coming back
- Lowering the risk of stroke and blood clots in adults with an irregular heartbeat called atrial fibrillation (when it is not caused by a heart valve problem)
- Preventing blood clots after a hip or knee replacement operation
- Lowering the risk of heart attack and stroke in some people with coronary heart disease or narrowed arteries in the legs (peripheral arterial disease), usually alongside other heart medicines
- In children and teenagers, treating blood clots and helping to stop them coming back, after injected treatment in hospital
Get medical help straight away if
- Call an ambulance straight away for signs of bleeding in the brain: a sudden severe headache, confusion, being sick, slurred speech, weakness on one side or trouble moving the arms or legs, a fit (seizure), a stiff neck or becoming very drowsy.
- Call an ambulance for signs of a severe allergic reaction: a swollen face, lips, tongue or throat, a raised itchy rash, or difficulty breathing or swallowing.
- Get urgent medical help after any head injury or bad fall, even if you feel fine.
- Get urgent help for heavy or internal bleeding: red, pink or brown urine; black, tarry or bloody stools; vomiting blood or material like coffee grounds; coughing up blood; bleeding in the eye; or bleeding from a cut, wound or nose that will not stop.
Side effects, warnings and interactions for Rivaroxaban
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Rivaroxaban
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Rivaroxaban is right for you and the dose.
- Atrial fibrillation: first choice to prevent stroke when stroke risk is raised
- Stroke: for people whose stroke was caused by atrial fibrillation
About Baroxa 15 mg tablet
Baroxa 15 mg tablet contains Rivaroxaban 15 mg. It is registered with DRAP by Aspin Pharma (registration no. 089304). Its official price is PKR 5,196.51 for a pack of 7's, about PKR 742.36 per tablet. This price has applied since 23 July 2026. It is sold in 3 pack sizes: 7's, 10's and 14's. Baroxa is also available as 10 mg tablet, 2.5 mg tablet and 20 mg tablet. 28 other brands of Rivaroxaban 15 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Baroxa 15 mg pack sizes and prices
Other strengths of Baroxa
All 28 other brands of Rivaroxaban 15 mg tablet in Pakistan
These 28 brands are alternatives (substitutes) to Baroxa: each contains Rivaroxaban 15 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Embex Forte (Shaigan Pharmaceuticals (Pvt) Ltd) at PKR 94.92 per tablet; the highest is Rivfaas at PKR 1,009. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Embex Forte | Shaigan Pharmaceuticals (Pvt) Ltd | 4x7's | PKR 2,657.67 | PKR 94.92 / tablet |
| Embex | Shaigan Pharmaceuticals (Pvt) Ltd | 14's | PKR 1,384.20 | PKR 98.87 / tablet |
| Xcept | PHARMEVO (PVT) LTD | 2x7's | PKR 7,520.93 | PKR 537 / tablet |
| Ivarlac | Nawan Laboratories Pvt Ltd | 10's | PKR 6,086.08 | PKR 609 / tablet |
| Rivaxo | Getz Pharma (Pvt) Limited | 10's | PKR 6,719.16 | PKR 672 / tablet |
| Rivaclot | Barrett Hodgson Pakistan (Pvt.) Ltd | 14's | PKR 9,407.07 | PKR 672 / tablet |
| Imroxavir | Cunningham Pharmaceuticals (Pvt.) Ltd | 7's | PKR 4,801.13 | PKR 686 / tablet |
| Ribax | M/s. Genix Pharma (Pvt) Ltd | 7's | PKR 4,801.13 | PKR 686 / tablet |
| Roxalis | Titlis Pharma (Private) Limited | 10's | PKR 7,051.07 | PKR 705 / tablet |
| Rivaro | Highnoon Laboratories Ltd | 10 | PKR 7,051.08 | PKR 705 / tablet |
| Taboxa | NovaMed Pharmaceuticals(Pvt.)Ltd | 10's | PKR 7,051.08 | PKR 705 / tablet |
| Alistair | Lucky Core Industries Limited | 10's | PKR 7,051.08 | PKR 705 / tablet |
| XALIA | CCL Pharmaceuticals (Pvt.) Limited | 10's | PKR 7,051.08 | PKR 705 / tablet |
| AXIOR | AsianContinental (Pvt.) Ltd | 14's | PKR 9,871.52 | PKR 705 / tablet |
| Raban | Mass Pharma (Pvt) Ltd | 14's | PKR 9,871.52 | PKR 705 / tablet |
| Verinoxa | Next Pharmaceutical Products (Pvt.) Ltd | 7's | PKR 4,951.89 | PKR 707 / tablet |
| Xariva | Nabiqasim Industries (Pvt) Ltd | 7's | PKR 4,951.89 | PKR 707 / tablet |
| Rivascot | Scotmann Pharmaceuticals | 7's | PKR 5,016.96 | PKR 717 / tablet |
| Raxbin | Saffron Pharmaceuticals | 10's | PKR 7,423.58 | PKR 742 / tablet |
| RXN | Scilife Pharma Private Limited | 10's | PKR 7,423.58 | PKR 742 / tablet |
Show all 28 brands
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| REVOBAN | Atco Laboratories Limited | 7's | PKR 5,196.51 | PKR 742 / tablet |
| MABINAT | Martin Dow Limited | 7's | PKR 5,196.51 | PKR 742 / tablet |
| Mazlero | Macter International Limited | 7's | PKR 5,196.51 | PKR 742 / tablet |
| Neurivox | Neutro Pharma (Pvt.) Ltd | 7's | PKR 5,196.51 | PKR 742 / tablet |
| AlistairTablets | Lucky Core Industries Limited | 7's | PKR 5,196.51 | PKR 742 / tablet |
| RIVAR | Hilton Pharma (Pvt) Limited | 7's | PKR 5,196.51 | PKR 742 / tablet |
| Xarelto | Bayer Pakistan Private Limited | 1 x 7's | PKR 6,112.77 | PKR 873 / tablet |
| Rivfaas | FAAS Pharmaceuticals (Pvt)Ltd | 14's | PKR 14,125.58 | PKR 1,009 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Baroxa, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Aspin Pharma, Karachi
- DRAP registration
- 089304
- Phone
- +92 21 111 515 515; +92 21 35045560-62
- info@aspin.com.pk
- Website
- https://aspin.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (7's). Current price PKR 5,196.51, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Baroxa 15 mg, 7's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/baroxa-15-mg-089304-10s-aspin-pharma/ (accessed 11 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 5,196.51 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 089304Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.